GE Aerospace stock slips on ex-dividend day as year-end trading thins — what’s next

GE Aerospace stock slips on ex-dividend day as year-end trading thins — what’s next

NEW YORK, December 29, 2025, 20:32 ET — Market closed

GE Aerospace shares fell $3.56, or 1.1%, to $311.58 on Monday.

The stock traded ex-dividend on Monday, meaning buyers from that day forward are no longer entitled to the next quarterly payout. GE Aerospace’s board declared a $0.36-per-share dividend payable on Jan. 26, 2026, to shareholders of record as of the close on Dec. 29. GE Aerospace

The timing matters because thin year-end trading can magnify routine calendar effects like dividends, while investors look ahead to the company’s next results for fresh guidance. GE Aerospace has scheduled its fourth-quarter 2025 earnings webcast for Jan. 22, 2026. GE Aerospace

GE’s decline came on a broadly weaker day for U.S. stocks. The S&P 500 fell 0.35% and the Dow Jones Industrial Average slid 0.51%, while GE underperformed peers such as Honeywell and RTX, and trading volume in GE was light. MarketWatch

The dividend itself is small relative to the share price — about 0.12% of Monday’s close — so the day’s drop points to more than a simple ex-dividend adjustment. Traders said year-end positioning and profit-taking after a run toward recent highs also weighed.

GE Aerospace is one of the world’s largest aircraft engine makers and service providers, with an installed base of about 49,000 commercial and 29,000 military aircraft engines. “Given the strength of our year-to-date results and our expectations for the fourth quarter, we’re raising our full-year guidance across the board,” CEO H. Lawrence Culp Jr. said in the company’s most recent quarterly results release. GE Aerospace

At the company’s last earnings update, GE Aerospace raised its 2025 adjusted profit forecast to a range of $6.00 to $6.20 per share, as it pointed to robust demand for aftermarket work — the higher-margin maintenance and spare-parts business tied to engines already in service. Reuters

With no fresh company announcement on Monday, investors focused on the broader tape and the turn-of-year calendar, including dividend mechanics and lighter liquidity.

Before Tuesday’s session, traders will watch U.S. housing and manufacturing data, with the S&P/Case‑Shiller home price index due at 9:00 a.m. ET and the Chicago PMI at 9:45 a.m. ET. The week’s other market mover is the release of FOMC meeting minutes on Wednesday at 2:00 p.m. ET. Scotiabank

The next company catalyst is late January, when investors will scrutinize whether GE can sustain services growth, expand output and hold cash flow as supply constraints and shop capacity remain key swing factors for the sector.

Technically, traders have flagged the recent 52-week high around $318 as a near-term resistance level, while the $300 area is the closest round-number support after the latest pullback.

For income-focused holders, the next checkpoint is the Jan. 26 dividend payment date, after Monday’s ex-dividend reset.

Stock Market Today

  • Raffles Medical Group: 3-Year Underperformance vs Market; EPS Decline, Mixed TSR
    December 29, 2025, 8:49 PM EST. Raffles Medical Group (SGX: BSL) has underperformed the market over the last three years, with the stock down about 27% versus a ~54% market gain. The downside was driven by a 15% CAGR decline in EPS over three years, while the share price fell 10% annually, suggesting investors may have priced in some deterioration. Despite the EPS slump, the company's dividends boosted total shareholder return (TSR), with a -21% TSR over three years that still beats the price return, and a 25% TSR over the last twelve months-though still below the broader market. The longer-term picture remains mixed; one warning sign has been identified, and the stock may not be the best buy for all investors. Readers are advised to review a free list of names with growing earnings before investing.
Disney stock ends higher as late SEC filing flags exec sale heading into final 2025 sessions
Previous Story

Disney stock ends higher as late SEC filing flags exec sale heading into final 2025 sessions

JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next
Next Story

JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next

Go toTop